Medicine | Oncology
Prostate cancer
Diagnosis
Screening and early detection


Home > Disciplines > Medicine > Oncology > Prostate cancer > Diagnosis > Screening


OVERVIEW


.

Carlsson SV, Lilja H.
Perspective on Prostate Cancer Screening.
Clin Chem. 2019 Jan;65(1):24-27. doi: 10.1373/clinchem.2018.293514. Epub 2018 Nov 20.
Source | Full text | Similar articles



.

Carroll PR, Parsons JK, Andriole G, Bahnson RR, Barocas DA, Castle EP, Catalona WJ, Dahl DM, Davis JW, Epstein JI, Etzioni RB, Farrington T, Hemstreet GP 3rd, Kawachi MH, Lange PH, Loughlin KR, Lowrance W, Maroni P, Mohler J, Morgan TM, Nadler RB, Poch M, Scales C, Shaneyfelt TM, Smaldone MC, Sonn G, Sprenke P, Vickers AJ, Wake R, Shead DA, Freedman-Cass D.
Prostate Cancer Early Detection, Version 2.2015.
J Natl Compr Canc Netw. 2015 Dec;13(12):1534-61.
Source | Full text | Similar articles



.

Grubb RL 3rd.
Prostate Cancer: Update on Early Detection and New Biomarkers.
Mo Med. 2018 Mar-Apr;115(2):132-134.
Source | Full text | Similar articles



.

Klotz L.
Laurence Klotz on the Controversy Surrounding Screening for Prostate Cancer.
Oncology (Williston Park). 2016 Aug 15;30(8). pii: 218393.
Source | Full text | Similar articles



.

Lynch HT, Kosoko-Lasaki O, Leslie SW, Rendell M, Shaw T, Snyder C, D'Amico AV, Buxbaum S, Isaacs WB, Loeb S, Moul JW, Powell I.
Screening for Familial and Hereditary Prostate Cancer.
Int J Cancer. 2015 Dec 5. doi: 10.1002/ijc.29949. [Epub ahead of print]
Source | Full text | Similar articles



.

Masterson TA, Cary C, Cheng L.
Early detection of prostate cancer: can we have our cake and eat it too?
Expert Rev Anticancer Ther. 2016 Jan 13. [Epub ahead of print]
Source | Full text | Similar articles



.

Shen X, Kumar P.
Trade-Off Between Treatment of Early Prostate Cancer and Incidence of Advanced Prostate Cancer in the Prostate Screening Era.
J Urol. 2015 Dec 2. pii: S0022-5347(15)05348-3. doi: 10.1016/j.juro.2015.11.056. [Epub ahead of print]
Source | Full text | Similar articles



.

Thompson IM Jr.
The pendulum swings back: Screening for prostate cancer in 2018.
Cancer. 2018 Jul 1;124(13):2690-2692. doi: 10.1002/cncr.31555. Epub 2018 May 22.
Comment on: Negoita S et al, Annual Report to the Nation on the Status of Cancer, part II: Recent changes in prostate cancer trends and disease characteristics. [Cancer. 2018 Jul 1]
Source | Full text | Similar articles



.

Tikkinen KAO, Dahm P, Lytvyn L, Heen AF, Vernooij RWM, Siemieniuk RAC, Wheeler R, Vaughan B, Fobuzi AC, Blanker MH, Junod N, Sommer J, Stirnemann J, Yoshimura M, Auer R, MacDonald H, Guyatt G, Vandvik PO, Agoritsas T.
Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline.
BMJ. 2018 Sep 5;362:k3581. doi: 10.1136/bmj.k3581.
Source | Full text | Similar articles



EFFICACY


.

Ilic D, Djulbegovic M, Jung JH, Hwang EC, Zhou Q, Cleves A, Agoritsas T, Dahm P.
Prostate cancer screening with prostate-specific antigen (PSA) test: a systematic review and meta-analysis.
BMJ. 2018 Sep 5;362:k3519. doi: 10.1136/bmj.k3519.
Source | Full text | Similar articles



GUIDELINES


.

US Preventive Services Task Force, Grossman DC, Curry SJ, Owens DK, Bibbins-Domingo K, Caughey AB, Davidson KW, Doubeni CA, Ebell M, Epling JW Jr, Kemper AR, Krist AH, Kubik M, Landefeld CS, Mangione CM, Silverstein M, Simon MA, Siu AL, Tseng CW.
Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
JAMA. 2018 May 8;319(18):1901-1913. doi: 10.1001/jama.2018.3710. Erratum in: JAMA. 2018 Jun 19;319(23):2443.
Source | Full text | Similar articles | Correction



REDUCING UNNECESSARY BIOPSY


.

Strope SA, Andriole GL.
Improving prostate-specific antigen screening.
J Clin Oncol. 2010 May 20;28(15):2491-2. doi: 10.1200/JCO.2009.26.9779. Epub 2010 Apr 26
Editorial relating to: Vickers A et al, Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication. J Clin Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.
Source | Full text | Similar articles



.

Vickers A, Cronin A, Roobol M, Savage C, Peltola M, Pettersson K, Scardino PT, Schröder F, Lilja H.
Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication.
J Clin Oncol. 2010 May 20;28(15):2493-8. doi: 10.1200/JCO.2009.24.1968. Epub 2010 Apr 26.
Source | Full text | Similar articles



DIGITAL RECTAL EXAMINATION


.

Naji L, Randhawa H, Sohani Z, Dennis B, Lautenbach D, Kavanagh O, Bawor M, Banfield L, Profetto J.
Digital Rectal Examination for Prostate Cancer Screening in Primary Care: A Systematic Review and Meta-Analysis.
Ann Fam Med. 2018 Mar;16(2):149-154. doi: 10.1370/afm.2205.
Source | Full text | Similar articles



IMPACT OF NSAIDs AND STATINS ON PSA LEVELS


.

Chang SL, Harshman LC, Presti JC Jr.
Impact of common medications on serum total prostate-specific antigen levels: analysis of the National Health and Nutrition Examination Survey.
J Clin Oncol. 2010 Sep 1;28(25):3951-7. doi: 10.1200/JCO.2009.27.9406. Epub 2010 Aug 2.
Source | Full text | Similar articles



MRI FOR PROSTATE CANCER SCREENING


.

Jones TA, Marks LS.
Re: A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
Eur Urol. 2017 Feb 20. pii: S0302-2838(17)30101-X. doi: 10.1016/j.eururo.2017.02.012. [Epub ahead of print]
Comment on: Nam RK, Wallis CJ, et al, A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.[ J Urol. 2016 Aug]
Source | Full text | Similar articles



.

Nam RK, Wallis CJ, Stojcic-Bendavid J, Milot L, Sherman C, Sugar L, Haider MA.
A Pilot Study to Evaluate the Role of Magnetic Resonance Imaging for Prostate Cancer Screening in the General Population.
J Urol. 2016 Aug;196(2):361-6. doi: 10.1016/j.juro.2016.01.114. Epub 2016 Feb 13.
Source | Full text | Similar articles



OPTIMAL TIME TO DISCONTINUE SCREENING


.

Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE.
Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
J Clin Oncol. 2011 May 1;29(13):1736-43. doi: 10.1200/JCO.2010.31.9004. Epub 2011 Mar 28.
Source | Full text | Similar articles



.

Vickers A.
Words of wisdom: Re: Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.
Eur Urol. 2011 Aug;60(2):392. doi: 10.1016/j.eururo.2011.05.021.
Source | Full text | Similar articles



SCREENING AND METASTASIS


.

Fontenot PA Jr, Nehra A, Parker W, Wyre H, Mirza M, Duchene DA, Holzbeierlein J, Thrasher JB, Van Veldhuizen P, Lee EK.
Metastatic prostate cancer in the modern era of PSA screening.
Int Braz J Urol. 2017 Mar 24;43. doi: 10.1590/S1677-5538.IBJU.2016.0340. [Epub ahead of print]
Source | Full text | Similar articles



CLINICAL TRIALS


.

Osses DF, Remmers S, Schröder FH, van der Kwast T, Roobol MJ.
Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-up.
Eur Urol. 2018 Nov 9. pii: S0302-2838(18)30851-0. doi: 10.1016/j.eururo.2018.10.053. [Epub ahead of print]
Source | Full text | Similar articles



.

Schröder FH, Hugosson J, Carlsson S, Tammela T, Määttänen L, Auvinen A, Kwiatkowski M, Recker F, Roobol MJ.
Screening for prostate cancer decreases the risk of developing metastatic disease: findings from the European Randomized Study of Screening for Prostate Cancer (ERSPC).
Eur Urol. 2012 Nov;62(5):745-52. doi: 10.1016/j.eururo.2012.05.068. Epub 2012 Jun 7.
Source | Full text | Similar articles



SCREENING AND PCa SPECIFIC MORTALITY




CLINICAL TRIALS


.

Andriole GL, Crawford ED, Grubb RL 3rd, Buys SS, Chia D, Church TR, Fouad MN, Gelmann EP, Kvale PA, Reding DJ, Weissfeld JL, Yokochi LA, O'Brien B, Clapp JD, Rathmell JM, Riley TL, Hayes RB, Kramer BS, Izmirlian G, Miller AB, Pinsky PF, Prorok PC, Gohagan JK, Berg CD; PLCO Project Team.
Mortality results from a randomized prostate-cancer screening trial.
N Engl J Med. 2009 Mar 26;360(13):1310-9. doi: 10.1056/NEJMoa0810696. Epub 2009 Mar 18. Erratum in: N Engl J Med. 2009 Apr 23;360(17):1797.
Source | Full text | Similar articles | Erratum



.

Gulati R, Albertsen PC.
Insights from the PLCO trial about prostate cancer screening.
Cancer. 2017 Feb 15;123(4):546-548. doi: 10.1002/cncr.30472. Epub 2016 Dec 1.
Source | Full text | Similar articles
Editorial referring to: Pinsky PF et al., Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474. Epub 2016 Dec 1.
Source / Full text



.

Osses DF, Remmers S, Schröder FH, van der Kwast T, Roobol MJ.
Results of Prostate Cancer Screening in a Unique Cohort at 19yr of Follow-up.
Eur Urol. 2018 Nov 9. pii: S0302-2838(18)30851-0. doi: 10.1016/j.eururo.2018.10.053. [Epub ahead of print]
Source | Full text | Similar articles



.

Pinsky PF, Miller E, Prorok P, Grubb R, Crawford ED, Andriole G.
Extended follow-up for prostate cancer incidence and mortality in the PLCO randomized cancer screening trial.
BJU Int. 2018 Oct 5. doi: 10.1111/bju.14580. [Epub ahead of print]
Source | Full text | Similar articles



.

Pinsky PF, Prorok PC, Yu K, Kramer BS, Black A, Gohagan JK, Crawford ED, Grubb RL, Andriole GL.
Extended mortality results for prostate cancer screening in the PLCO trial with median follow-up of 15 years.
Cancer. 2017 Feb 15;123(4):592-599. doi: 10.1002/cncr.30474.
Epub 2016 Dec 1.
Source | Full text | Similar articles



.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Zappa M, Nelen V, Kwiatkowski M, Lujan M, Määttänen L, Lilja H, Denis LJ, Recker F, Paez A, Bangma CH, Carlsson S, Puliti D, Villers A, Rebillard X, Hakama M, Stenman UH, Kujala P, Taari K, Aus G, Huber A, van der Kwast TH, van Schaik RH, de Koning HJ, Moss SM, Auvinen A; ERSPC Investigators.
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.
Lancet. 2014 Dec 6;384(9959):2027-35. doi: 10.1016/S0140-6736(14)60525-0. Epub 2014 Aug 6.
Source | Full text | Similar articles



.

Schröder FH, Hugosson J, Roobol MJ, Tammela TL, Ciatto S, Nelen V, Kwiatkowski M, Lujan M, Lilja H, Zappa M, Denis LJ, Recker F, Berenguer A, Määttänen L, Bangma CH, Aus G, Villers A, Rebillard X, van der Kwast T, Blijenberg BG, Moss SM, de Koning HJ, Auvinen A; ERSPC Investigators.
Screening and prostate-cancer mortality in a randomized European study.
N Engl J Med. 2009 Mar 26;360(13):1320-8. doi: 10.1056/NEJMoa0810084. Epub 2009 Mar 18.
Source | Full text | Similar articles



.

Tsodikov A, Gulati R, Heijnsdijk EAM, Pinsky PF, Moss SM, Qiu S, de Carvalho TM, Hugosson J, Berg CD, Auvinen A, Andriole GL, Roobol MJ, Crawford ED, Nelen V, Kwiatkowski M, Zappa M, Luján M, Villers A, Feuer EJ, de Koning HJ, Mariotto AB, Etzioni R.
Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials.
Ann Intern Med. 2017 Oct 3;167(7):449-455. doi: 10.7326/M16-2586. Epub 2017 Sep 5.
Source | Full text | Similar articles



.

Vickers AJ.
Prostate Cancer Screening: Time to Question How to Optimize the Ratio of Benefits and Harms.
Ann Intern Med. 2017 Oct 3;167(7):509-510. doi: 10.7326/M17-2012. Epub 2017 Sep 5.
Comment on: Tsodikov A et al, Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. [Ann Intern Med. 2017]
Source | Full text | Similar articles



.

Xia J, Gulati R, Au M, Gore JL, Lin DW, Etzioni R.
Effects of screening on radical prostatectomy efficacy: the prostate cancer intervention versus observation trial.
J Natl Cancer Inst. 2013 Apr 17;105(8):546-50. doi: 10.1093/jnci/djt017. Epub 2013 Feb 14.
Source | Full text | Similar articles



.

Zolot J.
Study Finds Overall Prostate Cancer Mortality Decreases with PSA Screening.
Am J Nurs. 2017 Dec;117(12):16. doi: 10.1097/01.NAJ.0000527472.38965.1f.
Comment on: Tsodikov A et al, Reconciling the Effects of Screening on Prostate Cancer Mortality in the ERSPC and PLCO Trials. [Ann Intern Med. 2017]
Source | Fulltext | Similar articles



SINGLE PSA SCREENING INTERVENTION


.

Barry MJ.
Screening for Prostate Cancer: Is the Third Trial the Charm?
JAMA. 2018 Mar 6;319(9):868-869. doi: 10.1001/jama.2018.0153. Erratum in: JAMA. 2018 Apr 10;319(14 ):1510
Comment on: Martin RM et al., Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018 Mar 6)
Source | Full text | Similar articles | Erratum



.

Kelsey R.
Prostate cancer: Solo PSA test does not lower mortality.
Nat Rev Urol. 2018 Mar 27. doi: 10.1038/nrurol.2018.41. [Epub ahead of print]
Comment on: Martin RM et al., Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial. (JAMA. 2018 Mar 6)
Source | Full text | Similar articles



.

Martin RM, Donovan JL, Turner EL, Metcalfe C, Young GJ, Walsh EI, Lane JA, Noble S, Oliver SE, Evans S, Sterne JAC, Holding P, Ben-Shlomo Y, Brindle P, Williams NJ, Hill EM, Ng SY, Toole J, Tazewell MK, Hughes LJ, Davies CF, Thorn JC, Down E, Davey Smith G, Neal DE, Hamdy FC; CAP Trial Group.
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial.
JAMA. 2018 Mar 6;319(9):883-895. doi: 10.1001/jama.2018.0154.
Source | Full text | Similar articles



BOOKS


.

Fenton JJ, Weyrich MS, Durbin S, Liu Y, Bang H, Melnikow J.
Prostate-Specific Antigen-Based Screening for Prostate Cancer: A Systematic Evidence Review for the U.S. Preventive Services Task Force [Internet].
PubMed Health, Rockville (MD): Agency for Healthcare Research and Quality (US); 2018 May.
Source | Book | Similar articles



.

Kramer BS et al, PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2017 Feb 15.
Source | Sections | Full text | Similar articles



.

Kramer BS et al, PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Patient Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2017 Feb 17.
Source | Sections | Full text | Similar articles




Miller Croswell J et al., PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Dec 13.
Source / Similar articles .




Miller Croswell J et al., PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Oct 18.
Source . Similar articles



.

Miller Croswell J et al., PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Aug 2.
Source | Book | Similar articles



.

Miller Croswell J et al., PDQ Screening and Prevention Editorial Board.
Prostate Cancer Screening (PDQ®): Health Professional Version.
PDQ Cancer Information Summaries [Internet]. Bethesda (MD): National Cancer Institute (US); 2019 Mar 22.
Source | Book | Similar articles